Suppr超能文献

通过CD47的血小板反应蛋白-1信号传导抑制内皮细胞的细胞周期进程并诱导其衰老。

Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells.

作者信息

Gao Qi, Chen Kexin, Gao Lu, Zheng Yang, Yang Yong-Guang

机构信息

The First Hospital and Institute of Immunology, Jilin University, Changchun, China.

Columbia Center for Translational Immunology, Columbia University College of Physicians and Surgeons, New York, NY, USA.

出版信息

Cell Death Dis. 2016 Sep 8;7(9):e2368. doi: 10.1038/cddis.2016.155.

Abstract

CD47 signaling in endothelial cells has been shown to suppress angiogenesis, but little is known about the link between CD47 and endothelial senescence. Herein, we demonstrate that the thrombospondin-1 (TSP1)-CD47 signaling pathway is a major mechanism for driving endothelial cell senescence. CD47 deficiency in endothelial cells significantly improved their angiogenic function and attenuated their replicative senescence. Lack of CD47 also suppresses activation of cell cycle inhibitors and upregulates the expression of cell cycle promoters, leading to increased cell cycle progression. Furthermore, TSP1 significantly accelerates replicative senescence and associated cell cycle arrest in a CD47-dependent manner. These findings demonstrate that TSP1-CD47 signaling is an important mechanism driving endothelial cell senescence. Thus, TSP1 and CD47 provide attractive molecular targets for treatment of aging-associated cardiovascular dysfunction and diseases involving endothelial dysregulation.

摘要

内皮细胞中的CD47信号已被证明可抑制血管生成,但关于CD47与内皮细胞衰老之间的联系却知之甚少。在此,我们证明血小板反应蛋白-1(TSP1)-CD47信号通路是驱动内皮细胞衰老的主要机制。内皮细胞中CD47的缺乏显著改善了它们的血管生成功能,并减弱了它们的复制性衰老。CD47的缺失还抑制了细胞周期抑制剂的激活并上调了细胞周期促进因子的表达,导致细胞周期进程加快。此外,TSP1以CD47依赖的方式显著加速复制性衰老和相关的细胞周期停滞。这些发现表明TSP1-CD47信号是驱动内皮细胞衰老的重要机制。因此,TSP1和CD47为治疗与衰老相关的心血管功能障碍和涉及内皮失调的疾病提供了有吸引力的分子靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/128d/5059850/fc5eb70ef1e6/cddis2016155f1.jpg

相似文献

3
The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1.
Sci Signal. 2017 Oct 17;10(501):eaaj1784. doi: 10.1126/scisignal.aaj1784.
5
CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis.
Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1234-1250. doi: 10.1161/ATVBAHA.122.318904. Epub 2023 Jun 1.
6
Roles of TSP1-CD47 signaling pathway in senescence of endothelial cells: cell cycle, inflammation and metabolism.
Mol Biol Rep. 2023 May;50(5):4579-4585. doi: 10.1007/s11033-023-08357-w. Epub 2023 Mar 10.
7
CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
J Biol Chem. 2006 Sep 8;281(36):26069-80. doi: 10.1074/jbc.M605040200. Epub 2006 Jul 11.
8
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment.
Cell Death Dis. 2019 Feb 27;10(3):199. doi: 10.1038/s41419-019-1406-7.
9
Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.
Matrix Biol. 2013 Aug 8;32(6):316-24. doi: 10.1016/j.matbio.2013.02.009. Epub 2013 Mar 13.
10
Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.
J Biol Chem. 2010 Dec 10;285(50):38923-32. doi: 10.1074/jbc.M110.172304. Epub 2010 Oct 5.

引用本文的文献

2
Targeting the CD47-SIRPalpha checkpoint in multiple myeloma.
Discov Oncol. 2025 Aug 25;16(1):1616. doi: 10.1007/s12672-025-03312-6.
3
CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD.
Front Endocrinol (Lausanne). 2025 Jun 24;16:1535382. doi: 10.3389/fendo.2025.1535382. eCollection 2025.
4
Regulating islet stress responses through CD47 activation.
Diabetologia. 2025 Jun;68(6):1279-1297. doi: 10.1007/s00125-025-06409-3. Epub 2025 Mar 25.
5
Blockade of TSP-1/CD47 signal axis promotes donor hematopoietic engraftment by improving SEC/MK niche function.
iScience. 2025 Feb 4;28(3):111952. doi: 10.1016/j.isci.2025.111952. eCollection 2025 Mar 21.
7
Alteration of skin fibroblast steady state contributes to healing outcomes.
bioRxiv. 2024 Dec 12:2024.12.06.627278. doi: 10.1101/2024.12.06.627278.
8
Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer.
Biomedicines. 2024 Sep 23;12(9):2152. doi: 10.3390/biomedicines12092152.
9
Deciphering the role of CD47 in cancer immunotherapy.
J Adv Res. 2024 Sep;63:129-158. doi: 10.1016/j.jare.2023.10.009. Epub 2023 Oct 28.
10
Cell autonomous functions of CD47 in regulating cellular plasticity and metabolic plasticity.
Cell Death Differ. 2024 Oct;31(10):1255-1266. doi: 10.1038/s41418-024-01347-w. Epub 2024 Jul 23.

本文引用的文献

1
Telomerase Therapy to Reverse Cardiovascular Senescence.
Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):172-5. doi: 10.14797/mdcj-11-3-172.
4
Defining vascular aging and cardiovascular risk.
J Hypertens. 2012 Jun;30 Suppl:S3-8. doi: 10.1097/HJH.0b013e328353e501.
6
CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.
Br J Pharmacol. 2012 Dec;167(7):1415-30. doi: 10.1111/j.1476-5381.2012.02099.x.
7
The intersection between aging and cardiovascular disease.
Circ Res. 2012 Apr 13;110(8):1097-108. doi: 10.1161/CIRCRESAHA.111.246876.
8
Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase.
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):712-20. doi: 10.1161/ATVBAHA.111.227389. Epub 2011 Dec 29.
9
The essence of senescence.
Genes Dev. 2010 Nov 15;24(22):2463-79. doi: 10.1101/gad.1971610.
10
Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.
Blood. 2010 Jun 3;115(22):4605-13. doi: 10.1182/blood-2009-09-242065. Epub 2010 Jan 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验